Compare DTM & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DTM | PEN |
|---|---|---|
| Founded | 2021 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7B | 12.9B |
| IPO Year | 2021 | 2015 |
| Metric | DTM | PEN |
|---|---|---|
| Price | $134.45 | $332.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 17 |
| Target Price | $141.80 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 735.3K | 503.4K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.67% | N/A |
| EPS Growth | 19.44 | ★ 1155.56 |
| EPS | 4.30 | ★ 4.52 |
| Revenue | $1,243,000,000.00 | ★ $1,403,665,000.00 |
| Revenue This Year | $7.56 | $14.34 |
| Revenue Next Year | $5.98 | $13.71 |
| P/E Ratio | ★ $30.59 | $73.38 |
| Revenue Growth | ★ 26.71 | 17.50 |
| 52 Week Low | $91.33 | $221.26 |
| 52 Week High | $143.15 | $362.41 |
| Indicator | DTM | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 48.96 | 47.90 |
| Support Level | $130.63 | $326.58 |
| Resistance Level | $137.77 | $338.99 |
| Average True Range (ATR) | 3.18 | 2.20 |
| MACD | -0.29 | 0.43 |
| Stochastic Oscillator | 53.63 | 63.10 |
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates maximum revenue from pipeline segment that includes interstate pipelines, storage systems, gathering lateral pipelines and compression and surface facilities.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.